Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
2005 · Journal of Clinical Oncology · 1,143 citations
https://doi.org/10.1200/jco.2004.00.4960
R
Rolf Fimmers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
472
Papers
21.5K
Citations
79
h-index
298
i10-index
Rolf Fimmers is an academic researcher. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Forensic and Genetic Research & Molecular Biology Techniques and Applications. The author has an h-index of 79, co-authored 402 publications.
ORCID: 0000-0001-7485-6803Papers by this author
worksLomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
2019 · The Lancet · 556 citations
https://doi.org/10.1016/s0140-6736(18)31791-4
The Spectrum of Long‐term Epilepsy–associated Tumors: Long‐term Seizure and Tumor Outcome and Neurosurgical Aspects
2003 · Epilepsia · 454 citations
https://doi.org/10.1046/j.1528-1157.2003.56102.x
Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate
2003 · Journal of Clinical Oncology · 158 citations
https://doi.org/10.1200/jco.2003.12.060
Qigong exercise for the symptoms of Parkinson's disease: A randomized, controlled pilot study
2005 · Movement Disorders · 153 citations
https://doi.org/10.1002/mds.20705
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial)
2020 · European Journal of Nuclear Medicine and Molecular Imaging · 124 citations
https://doi.org/10.1007/s00259-020-04797-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat